182 related articles for article (PubMed ID: 16185887)
1. Regulation of protein synthesis in lymphoblasts from vanishing white matter patients.
van Kollenburg B; Thomas AA; Vermeulen G; Bertrand GA; van Berkel CG; Pronk JC; Proud CG; van der Knaap MS; Scheper GC
Neurobiol Dis; 2006 Mar; 21(3):496-504. PubMed ID: 16185887
[TBL] [Abstract][Full Text] [Related]
2. The large spectrum of eIF2B-related diseases.
Fogli A; Boespflug-Tanguy O
Biochem Soc Trans; 2006 Feb; 34(Pt 1):22-9. PubMed ID: 16246171
[TBL] [Abstract][Full Text] [Related]
3. Defective translation initiation causes vanishing of cerebral white matter.
Scheper GC; Proud CG; van der Knaap MS
Trends Mol Med; 2006 Apr; 12(4):159-66. PubMed ID: 16545608
[TBL] [Abstract][Full Text] [Related]
4. Subunits of the translation initiation factor eIF2B are mutant in leukoencephalopathy with vanishing white matter.
Leegwater PA; Vermeulen G; Könst AA; Naidu S; Mulders J; Visser A; Kersbergen P; Mobach D; Fonds D; van Berkel CG; Lemmers RJ; Frants RR; Oudejans CB; Schutgens RB; Pronk JC; van der Knaap MS
Nat Genet; 2001 Dec; 29(4):383-8. PubMed ID: 11704758
[TBL] [Abstract][Full Text] [Related]
5. [From gene to disease; a defect in the regulation of protein production leading to vanishing white matter].
Pronk JC; Leegwater PA; van der Knaap MS
Ned Tijdschr Geneeskd; 2002 Oct; 146(41):1933-6. PubMed ID: 12404908
[TBL] [Abstract][Full Text] [Related]
6. Leukoencephalopathy with vanishing white matter: a review.
Bugiani M; Boor I; Powers JM; Scheper GC; van der Knaap MS
J Neuropathol Exp Neurol; 2010 Oct; 69(10):987-96. PubMed ID: 20838246
[TBL] [Abstract][Full Text] [Related]
7. The spectrum of mutations for the diagnosis of vanishing white matter disease.
Scali O; Di Perri C; Federico A
Neurol Sci; 2006 Sep; 27(4):271-7. PubMed ID: 16998732
[TBL] [Abstract][Full Text] [Related]
8. The unfolded protein response in vanishing white matter disease.
van der Voorn JP; van Kollenburg B; Bertrand G; Van Haren K; Scheper GC; Powers JM; van der Knaap MS
J Neuropathol Exp Neurol; 2005 Sep; 64(9):770-5. PubMed ID: 16141786
[TBL] [Abstract][Full Text] [Related]
9. Decreased guanine nucleotide exchange factor activity in eIF2B-mutated patients.
Fogli A; Schiffmann R; Hugendubler L; Combes P; Bertini E; Rodriguez D; Kimball SR; Boespflug-Tanguy O
Eur J Hum Genet; 2004 Jul; 12(7):561-6. PubMed ID: 15054402
[TBL] [Abstract][Full Text] [Related]
10. Vanishing white matter disease: a review with focus on its genetics.
Pronk JC; van Kollenburg B; Scheper GC; van der Knaap MS
Ment Retard Dev Disabil Res Rev; 2006; 12(2):123-8. PubMed ID: 16807905
[TBL] [Abstract][Full Text] [Related]
11. Mutations in each of the five subunits of translation initiation factor eIF2B can cause leukoencephalopathy with vanishing white matter.
van der Knaap MS; Leegwater PA; Könst AA; Visser A; Naidu S; Oudejans CB; Schutgens RB; Pronk JC
Ann Neurol; 2002 Feb; 51(2):264-70. PubMed ID: 11835386
[TBL] [Abstract][Full Text] [Related]
12. Mutational analysis of the alpha subunit of eIF2B provides insights into the role of eIF2B bodies in translational control and VWM disease.
Norris K; Hodgson RE; Dornelles T; Allen KE; Abell BM; Ashe MP; Campbell SG
J Biol Chem; 2021; 296():100207. PubMed ID: 33334879
[TBL] [Abstract][Full Text] [Related]
13. Mutations linked to leukoencephalopathy with vanishing white matter impair the function of the eukaryotic initiation factor 2B complex in diverse ways.
Li W; Wang X; Van Der Knaap MS; Proud CG
Mol Cell Biol; 2004 Apr; 24(8):3295-306. PubMed ID: 15060152
[TBL] [Abstract][Full Text] [Related]
14. [Eukaryotic translation initiation factor 2B and leukoencephalopathy with vanishing white matter].
Pan YX; Wu Y; Niu ZP; Jiang YW
Beijing Da Xue Xue Bao Yi Xue Ban; 2009 Oct; 41(5):608-10. PubMed ID: 19829687
[TBL] [Abstract][Full Text] [Related]
15. Glia-specific activation of all pathways of the unfolded protein response in vanishing white matter disease.
van Kollenburg B; van Dijk J; Garbern J; Thomas AA; Scheper GC; Powers JM; van der Knaap MS
J Neuropathol Exp Neurol; 2006 Jul; 65(7):707-15. PubMed ID: 16825957
[TBL] [Abstract][Full Text] [Related]
16. [Natural history of adult-onset eIF2B-related disorders: a multicentric survey of 24 cases].
Carra-Dalliere C; Horzinski L; Ayrignac X; Vukusic S; Rodriguez D; Mauguiere F; Peter L; Goizet C; Bouhour F; Denier C; Confavreux C; Obadia M; Blanc F; de Seze J; Sedel F; Guennoc AM; Sartori E; Laplaud D; Antoine JC; Fogli A; Boespflug-Tanguy O; Labauge P
Rev Neurol (Paris); 2011 Nov; 167(11):802-11. PubMed ID: 21676421
[TBL] [Abstract][Full Text] [Related]
17. Intra-familial phenotypic heterogeneity in adult onset vanishing white matter disease.
Damon-Perriere N; Menegon P; Olivier A; Boespflug-Tanguy O; Niel F; Creveaux I; Dousset V; Brochet B; Goizet C
Clin Neurol Neurosurg; 2008 Dec; 110(10):1068-71. PubMed ID: 18845387
[TBL] [Abstract][Full Text] [Related]
18. Dominant form of vanishing white matter-like leukoencephalopathy.
Labauge P; Fogli A; Castelnovo G; Le Bayon A; Horzinski L; Nicoli F; Cozzone P; Pagès M; Briere C; Marty-Double C; Delhaume O; Gelot A; Boespflug-Tanguy O; Rodriguez D
Ann Neurol; 2005 Oct; 58(4):634-9. PubMed ID: 16047349
[TBL] [Abstract][Full Text] [Related]
19. Leucoencephalopathy with vanishing white matter may cause progressive myoclonus epilepsy.
Jansen AC; Andermann E; Niel F; Creveaux I; Boespflug-Tanguy O; Andermann F
Epilepsia; 2008 May; 49(5):910-3. PubMed ID: 18266750
[TBL] [Abstract][Full Text] [Related]
20. Identification of ten novel mutations in patients with eIF2B-related disorders.
Ohlenbusch A; Henneke M; Brockmann K; Goerg M; Hanefeld F; Kohlschütter A; Gärtner J
Hum Mutat; 2005 Apr; 25(4):411. PubMed ID: 15776425
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
